Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.47 |
| ▸ | CA2 | P00918 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | RORA | P35398 | 1/20 | 0.38 |
| ▸ | RORC | P51449 | 1/20 | 0.38 |
| ▸ | RORB | Q92753 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29370905 | 1.00 | ALDH1A1 (0.47) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL29369013 | 0.87 | ALDH1A1 (0.43) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL23089891 | 0.87 | ALDH1A1 (0.43) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL29362343 | 0.87 | ALDH1A1 (0.54) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL1401911 | 0.87 | ALDH1A1 (0.54) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL20398484 | 0.85 | ALDH1A1 (0.45) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL30434150 | 0.85 | ALDH1A1 (0.47) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL20398563 | 0.84 | ALDH1A1 (0.48) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL23089939 | 0.84 | ALDH1A1 (0.44) | ALDH1A1CYP3A4CA2LMNAPRSS1 | |
| SCHEMBL29371001 | 0.84 | ALDH1A1 (0.44) | ALDH1A1CYP3A4CA2LMNAPRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11613509-B2 | Radical polymerization control agent and radical polymerization control method | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2023-03-28 | — | — | US | disclosed |
| US-11352450-B2 | Photopolymerization sensitizer composition | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2022-06-07 | — | — | US | disclosed |
| US-20210122692-A1 | RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2021-04-29 | — | — | US | disclosed |
| US-20210079127-A1 | PHOTOPOLYMERIZATION SENSITIZER COMPOSITION | KAWASAKI KASEI CHEMICALS LTD. (JP) | 2021-03-18 | — | — | US | disclosed |
| US-8025386-B2 | Inkjet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC INC. (JP) | 2011-09-27 | — | — | US | disclosed |
| US-20110165387-A1 | ACTINIC ENERGY RADIATION CURABLE INK-JET INK, IMAGE FORMING METHOD USING THE SAME, AND PRINTED MATTER OBTAINED THEREBY | KONICA MINOLTA IJ TECHNOLOGIES, INC. (JP) | 2011-07-07 | — | — | US | disclosed |
| EP-2266812-A2 | Image forming method using actinic energy radiation curable ink-jet ink and printed matter obtained thereby | Konica Minolta IJ Technologies, Inc. (JP) | 2010-12-29 | — | — | EP | disclosed |
| US-20080151029-A1 | INKJET RECORDING APPARATUS | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11613509-B2 | Radical polymerization control agent and radical polymerization control method | PPOX, NOX4, CROCC | ALDH1A1 1023/4885CYP3A4 726/4885CA2 1806/4885 |
| US-20210122692-A1 | RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD | PPOX, NOX4, CROCC | ALDH1A1 1023/4885CYP3A4 726/4885CA2 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.